TABLE 4.
Pharmacists’ interventions and counseling aspects provided during telepharmacy service
| Pharmacists’ recommendations | Number of patients (%) a |
|---|---|
| Pharmacological measures | |
| Dietary supplement | 10 (14.1%) |
| Drug, topical use | 5 (7%) |
| OTC, systemic use | 3 (4.2%) |
| Herbal drug | 1 (1.4%) |
| Non‐pharmacological measures | |
| Adherence | 8 (11.3%) |
| Nutrition | 6 (8.5%) |
| Physical activity | 5 (7%) |
| Hydration | 3 (4.2%) |
| Blood glucose self‐measurement | 1 (1.4%) |
| Other measures (posture and decreasing risk of falls) | 7 (9.9%) |
| Referral to a doctor for refill/prescribing purposes | 11 (15.5%) |
| Referral to a doctor in case of a disease/state progression | 8 (11.3%) |
| Psychological support | 7 (9.9%) |
| Drug‐related interventions/counseling aspects | |
| Information on drug shortages | 27 (38%) |
| Information on available generics on the market | 17 (23.9%) |
| Adverse drug effects | 10 (14.1%) |
| Accurate drug administration | 7 (9.9%) |
| Proposing a substitution therapy due to drug shortages | 6 (8.5%) |
| Accurate dosage regimen (dose and dosing interval) | 4 (5.6%) |
| Information on drug prescription regimen | 3 (4.2%) |
| Duration of therapy | 3 (4.2%) |
| Drug prescription refill | 3 (4.2%) |
| Financial constraints | 3 (4.2%) |
| Mechanism of drug action and therapy efficacy | 2 (2.8%) |
| Identification of drug duplication | 1 (2.8%) |
| Checking for contraindications or precautions | 1 (1.4%) |
| Checking for clinically significant drug‐drug interactions | 1 (1.4%) |
| Drug administration related to meal | 1 (1.4%) |
| COVID−19‐related counseling aspects | |
| Information on recommended disinfectants | 3 (4.2%) |
| Available pharmacological therapeutic options | 2 (2.8%) |
| Explanation of social distancing measures | 2 (2.8%) |
| Masks availability on the market | 1 (1.4%) |
Abbreviation: OTC, over the counter.
a
The values do not add up to 100%, as there were multiple interventions recorded for the patients.